Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Recruiting 2Completed 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 25Gastrointestinal 24Head & Neck 8Other hematologic neoplasm 7Thoracic 4Sarcoma 3Plasma cell 3Lymphoid 3Classical hematology 3Myeloid 2Other neoplasm 1Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1732Lymphoma 1728Lymphoma, Non-Hodgkin 1202Leukemia, Lymphocytic, Chronic, B-Cell 1120Lymphoma, Follicular 1067Lymphoma, Large B-Cell, Diffuse 1059Hodgkin Disease 906Leukemia 875Lymphoma, Mantle-Cell 738Leukemia, Myeloid, Acute 662Burkitt Lymphoma 603Multiple Myeloma 556Lymphoma, B-Cell, Marginal Zone 546Myelodysplastic Syndromes 507Recurrence 449Lymphoma, B-Cell 414Lymphoma, Large-Cell, Immunoblastic 328Waldenstrom Macroglobulinemia 323Lymphoma, T-Cell, Cutaneous 322Mycosis Fungoides 277Neoplasms 255Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 249Myeloproliferative Disorders 249Neoplasms, Plasma Cell 242Sezary Syndrome 231Leukemia, Myelogenous, Chronic, BCR-ABL Positive 221Lymphoma, Large-Cell, Anaplastic 215Leukemia, Myeloid, Accelerated Phase 211Lymphoma, T-Cell, Peripheral 203Blast Crisis 203

Interventions

thymoglobulin 1fludarabine phosphate 1fludarabine 1Whole-Body Irradiation 1Tacrolimus 1Rituximab 1Observation 1Mycophenolic Acid 1Methotrexate 1Melphalan 1Cyclophosphamide 1Clofarabine 1Busulfan 1Bone Marrow Transplantation 1Blood Specimen Collection 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Pathologic Complete Response × Lymphoid × Clear all
NCT07353840 2026-01-20

T-START-CR

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Recruiting
160 enrolled
Lymphoid

Pathologic Complete Response, Lymphoma, T-Cell, Peripheral

NCT04314219 2025-03-13

PTCy-PMAT

King Faisal Specialist Hospital & Research Center

Phase 3 Recruiting
264 enrolled
LymphoidOther hematologic neoplasm

Pathologic Complete Response, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01471067 2017-04-28

Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

M.D. Anderson Cancer Center

Phase 1 Completed
33 enrolled
LymphoidMyeloidOther hematologic neoplasm

Pathologic Complete Response, Histiocytosis, Langerhans-Cell, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Philadelphia Chromosome, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡